First-of-its-kind examination shows how widely pharma showers campaign cash at the state level
(By Lev Facher for STAT) By the time Will Guzzardi, a state legislator in Illinois, called a vote on his
Read moreElections – Healthcare issues
As Trump Touts His ‘Great’ COVID Drugs, the Pharma Cash Flows to Biden, Not Him
(By Jay Hancock for Kaiser Health News) Pharmaceutical giants Regeneron and Gilead Sciences got the kind of publicity money can’t
Read moreNew Research Suggests In-Person Voting May Be Less Risky Than Previously Thought
(By David Welna for NPR) Amid widespread alarm about the ability of the embattled U.S. Postal Service to deliver mailed
Read moreSanders releases ‘Medicare for All’ funding details
(By Emily Rappleye for Becker’s Hospital Review) Democratic presidential candidate Sen. Bernie Sanders, I-Vt., revealed a long-awaited funding plan on
Read moreNewsom Touts California’s ‘Public Option.’ Wait — What Public Option?
(By Ana B. Ibarra for Kaiser Health News) Several Democratic presidential hopefuls are pitching a federal “public option” as a
Read moreIt’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats
(By Lev Facher for STAT) WATERLOO, Iowa — Presidential candidates can’t stop talking about insulin. At a campaign stop here
Read moreDemocrats Debate Whether ‘Medicare For All’ Is ‘Realistic’
(By Emmarie Huettman for Kaiser Health News) In the end, literally, the candidates returned to health care. The sixth Democratic
Read moreWarren’s ‘Medicare for All’ funding plan: 8 things to know
(By Molly Gamble for Becker’s Hospital Review) Nearly a week after promising a funding plan for her “Medicare for All” policy, Sen.
Read moreSanders on ‘Medicare for All’ funding: ‘I don’t think I have to do that right now’
(By Emily Rappleye for Becker’s Hospital Review) Democratic presidential candidate Sen. Bernie Sanders, I-Vt., said he believes his $30 trillion
Read more5 updates on ‘Medicare for All’
(By Morgan Haefner for Becker’s Hospital Review) Here are five updates on issues surrounding “Medicare for All” proposals published by Becker’s
Read more